15 July 2026
MOH refutes Pharmaniaga's claim that the government spent more on originators than generics in 2025, clarifying that MOH spent RM3 billion on generics, comprising 78% of its RM3.86 billion drug budget, while RM850 million (22%) was spent on innovators.